Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at raps@raps.org if you need assistance.
The site navigation utilizes arrow, enter, escape, and space bar key commands. Left and right arrows move across top level links and expand / close menus in sub levels. Up and Down arrows will open main level menus and toggle through sub tier links. Enter and space open menus and escape closes them as well. Tab will move on to the next part of the site rather than go through menu items.
The regulatory function is vital in making safe and effective healthcare products available worldwide. Individuals who ensure regulatory compliance and prepare submissions, as well as those whose main job function is clinical affairs or quality assurance are all considered regulatory professionals.
Share your knowledge and expertise with your regulatory peers by submitting an in-depth, evidence-based article focusing on key areas and emerging issues in the global regulatory landscape.
One of our most valuable contributions to the profession is the Regulatory Code of Ethics. The Code of Ethics provides regulatory professionals with core values that hold them to the highest standards of professional conduct.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Like all professions, regulatory is based on a shared set of competencies. The Regulatory Competency Framework describes the essential elements of what is required of regulatory professionals at four major career and professional levels.
Registration is now open for RAPS Convergence 2021! Gather with the regulatory community 12-15 September for four days of learning, engagement, and excitement.
Keep the sparks coming! Delegates of the conference have access to on-demand content until the end of October 2021.
This updated edition is a great reference for anyone working in multinational product development and marketing.
Regipedia is an interactive resource created to benefit RAPS members with 24/7 access to more than 2,300 regulatory terms.
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
Sign in to register as a Member Not a member? Join Today!
Register as a Nonmember
Thursday, 14 October 2021 (9:00 AM) - Friday, 15 October 2021 (5:00 PM) Central European Time
Complying with the new EU Requirements for IVD’s is expected to become very challenging for IVD manufacturers, some say even more than the MDR. The leaving point for many manufacturers is the IVD Directive that came into force in the year 2003. In the meantime, much has changed.
As a result of the introduced IVDR, manufacturers that currently place IVD’s on the EU Community market will encounter the new reality; facing scrutiny by EU Notified Bodies and Competent Authorities, installing a Person Responsible for Regulatory Compliance, carrying out additional testing and even performance investigations. For a large portion of the IVD manufacturers, this reality will be apparent as of the date of application - 26 May 2022 - since a large portion of IVD devices will need to comply after that date without the reliance on market access through the current IVDD certificate. Although this date may still seem to be far in the future, there is a lot that IVD manufacturers need to do in order to prepare.
This workshop will cover these big themes of the IVDR alongside with hands-on information on how to tackle the most important requirements. Elements that are going to be covered are:
The potential impact of the IVDR for new and existing (legacy) devices will be discussed together with important considerations for determining the appropriate regulatory pathway and application strategy
From now–12 September 2021: Early Bird Member 660euro | Nonmember 740 euro
13 September 2021-13 Oktober 2021: Regular Member 740 euro | Nonmember 825euro
Upon completion of this session, participants should be able to:
Regulatory affairs professionals (entry level, specialists, managers and directors)
We will use a traditional slide presentation combined with practical worked examples and case studies to engage attendees throughout the session as well as encouraging attendees to come forward with their own practical questions.
Key words: Notified Bodies, Clinical Evidence, EU Market Surveillance, PRRC, Quality Systems, Technical Documentation, Post Market Surveillance
Alex Laan Principal Consultant NAMSA
Alex Laan currently holds the position of Principal Consultant at NAMSA. Until recently, Alex worked as Principal Certification Manager at DEKRA Certification BV, Notified Body for (IVD) Medical Devices located in Arnhem, The Netherlands. After starting at KEMA Quality in 2006, Alex was qualified for Lead Assessor for Medical Devices and IVD devices, Device Specialist reviewer in IVD's and Medical Devices, including drug-device combinations. Active member of IVD working group within EU Notified Bodies and TEAM-NB. Acting as direct contact for EU competent authorities. Alex has an education as engineer (Dipl.-Ing) in Bioprocesstechnology and Biochemistry. Previously, Alex worked as a product specialist in immunohematological products and plasma products with Sanquin Blood Transfusion Services, Amsterdam, after which he started his career working as a QA and RA manager for IVD Medical devices at Meddens Diagnostics / IBL Hamburg.